Abstract
BACKGROUND: Ipilimumab (Yervoy (R)) therapy improves outcomes in patients with resected stage III melanoma, and ipilimumab alone or combined with nivo......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
